Endpoints News 2026年3月3日 After years of dispute with FDA, Vanda will get a public hearing for jet lag drug
Endpoints News 2026年3月3日 FDA explains how some copycat drugs can still win three years of exclusivity
Endpoints News 2026年3月3日 EveryOne Medicines shuts down, ending custom cure venture that banked on new FDA pathway
Endpoints News 2026年3月3日 Boehringer Ingelheim tried to use a tempting, tough cancer target for liver disease. It didn’t work
Endpoints News 2026年3月2日 Aardvark's stock plummets on study pause; BioNTech heads to Phase 3 with DualityBio ADC
Endpoints News 2026年3月2日 Roche gets third pivotal win with MS drug, but liver signal could be a problem